Production & Manufacturing
Production & Manufacturing
ADIENNE Pharma signs manufacturing deal with Selexis
ADIENNE Pharma & Biotech has signed a service agreement with Selexis for the development of a manufacturing cell line for one of the ADIENNE's orphan drugs. Selexis CEO Igor Fisch said, "Combining our expertise...
Production & Manufacturing
Indian state plans non-generic drugs procurement for government hospitals
Indian state of Uttar Pradesh is planning to procure non-generic drugs directly from the manufacturing companies for usage in government hospitals in the state. The state government is formulating a new drug policy that...
Production & Manufacturing
Natco Pharma wins license to manufacture, sell Nexavar in India
The Indian patents office has awarded a license to Natco Pharma to manufacture and sell a generic version of Bayer's cancer treatment drug Nexavar. As per the Indian Patents Act, Natco Pharma will be...
Production & Manufacturing
BioLife Solutions to build second GMP production facility
BioLife Solutions has executed an amendment to its current commercial lease to double the area of its existing facilities. The additional space will be used to the build a second GMP manufacturing clean room...
Production & Manufacturing
Eurogentec drug substance manufacturing facility wins FDA nod
The FDA has granted acceptable status, under its current regulatory guidelines, to Eurogentec's Seraing, Belgium drug substance manufacturing facility. The status will allow Eurogentec to manufacture a commercial bulk parenteral biopharmaceutical for one of its...
Production & Manufacturing
Dainippon wins manufacturing approval for sleep inducing therapy in Japan
Dainippon Sumitomo Pharma has obtained manufacturing and marketing approval for Zolpidem tartrate tablets 5mg/10mg from the Ministry of Health, Labour and Welfare in Japan. Zolpidem tartrate tablets 5mg/10mg are film-coated tablets containing 5mg...
Production & Manufacturing
EMA approves Genzyme Framingham manufacturing plant
The European Medicines Agency (EMA) has approved Genzyme’s manufacturing plant in Framingham, Massachusetts, US for the production of Fabrazyme (agalsidase beta). Fabrazyme (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.